SMAD3 and rheumatoid arthritis: Compared to controls, TGF-β/Smad3 signaling was highly activated in the synovial tissues of RA patients as identified by overexpressing TGF-β1, TGF-β receptor II (TβRII), and phospho-Smad3 nuclear translocation (Figures 1A–C).